Dr. Aaron Fabian Brafman, MD

Dr. Brafman practices at Novamed Surgery Center of Coral Springs LLC in Coral Springs, Florida.

Dr. Brafman's NPI, 1730441841, was assigned on June 14, 2012. Dr. Brafman graduated from Boston University School Of Medicine in 2012. Dr. Brafman holds Florida license ME131193.

Dr. Brafman's primary practice is Novamed Surgery Center of Coral Springs LLC, at 1725 University Dr, Coral Springs, FL 33071 in Broward County. The practice phone is (954) 227-7760.

Dr. Brafman's primary practice is Novamed Surgery Center of Coral Springs LLC in Coral Springs, Florida. Dr. Brafman is also affiliated with Broward Health Coral Springs. The medical group on file is GenesisCare. Dmand AI also links Dr. Brafman to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brafman practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Brafman's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Brafman is board certified in urology by the American Board of Urology. Dr. Brafman is licensed in Florida.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney removal surgery, kidney stone disease, prostate cancer and prostate inflammation or infection among the conditions Dr. Brafman treats.

CMS data shows 3,977 Medicare services from Dr. Brafman across 23 procedure codes in 2024, for 472 Medicare patients. Medicare paid $178,717 for them.

CMS counts 472 Medicare patients who saw Dr. Brafman in 2024. The largest group is 65 to 74, with 243 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brafman's median patient age at 68, with 21% women.

In 2024, Dr. Brafman wrote 3,007 Medicare Part D claims for 707 patients. 83% of them were for generic drugs. CMS names the drug for 2,811 of them, across 43 drugs with 11 or more claims each, at $2,017,685 in total drug cost. In 2023, CMS named 2,608 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Brafman for performance year 2024, reported individually. Dr. Brafman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brafman as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Brafman in 2016. Dr. Brafman's most frequent co-author is Vincent Gerard Bird, MD.

CMS Open Payments shows 590 general payments to Dr. Brafman from 61 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,595.

Dr. Brafman graduated from Boston University School Of Medicine in 2012. Dr. Brafman is a member of AMA and AUA.

Dr. Brafman is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.